Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News Macquarie Asset Management and Sol Systems invest $85m in solar energy projects in Illinois and Ohio Macquarie Asset Management and Sol Systems have jointly announced a substantial $85 million debt investment to support the… byPallavi MadhirajuJune 3, 2024